Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances

Daily Values

Growth Metrics

Icu Medical (ICUI) Other financing activities (2022)

Icu Medical's Other financing activities history spans 9 years, with the latest figure at $325000.0 for Q4 2022.

For the quarter ending Q4 2022, Other financing activities changed N/A year-over-year to $325000.0, compared with a TTM value of $325000.0 through Sep 2023, down 82.45%, and an annual FY2025 reading of $2.8 million, changed N/A over the prior year.
Other financing activities for Q4 2022 was $325000.0 at Icu Medical, down from $1.9 million in the prior quarter.
The five-year high for Other financing activities was $1.9 million in Q1 2022, with the low at $325000.0 in Q4 2022.